WASHINGTON—The U.S. Department of Commerce is investigating potential national security impacts of importing some medical devices and consumables, including durable medical equipment and personal protective equipment.
On Friday, the administration published a notice in the Federal Register requesting public comments. It says the investigation includes:
- Personal protective equipment used in health care settings
- Medical consumables, including catheters, tracheostomy tubes and some wound care items
- Medical equipment including, hospital beds, wheelchairs, insulin pumps, blood glucose monitors, orthopedic appliances, respirators, ventilators and oxygen machines
The investigation, which comes under Section 232 of the Trade Expansion Act of 1962, could lead to the administration imposing tariffs or other import restrictions on some goods.
The Federal Register posting says the investigation and request for comments is focused on determining the current and projected demand for medical equipment, personal protective equipment (PPE) and medical consumables and whether domestic production could meet U.S. needs or be increased if necessary.
Scott Whitaker, president and CEO of Advamed, an association for the medtech industry, said that 70% of medical technology and equipment used by American hospitals and patients is made in the United States.
“We believe this process will reinforce the fact that U.S. medtech manufacturing is strong and lower tariffs will fuel more manufacturing and job growth in the U.S., which means greater access to lifesaving technologies and lower costs to American hospitals and patients,” Whitaker said in a statement.
Reuters reported that some medical equipment manufacturers saw their stocks fall after the news, including ResMed, Medtronic and Abbot.
According to the law firm of Case and White, Section 232 investigations can run for 270 days, but the administration has indicated it intends to move more quickly. The public comment period closes Oct. 17.